Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.
The identification of prognostic tumor biomarkers that also would have potential as therapeutic targets, particularly in patients with early stage disease, has been a long sought-after goal in the management and treatment of lung cancer. The nuclear receptor (NR) superfamily, which is composed of 48...
Main Authors: | Yangsik Jeong, Yang Xie, Guanghua Xiao, Carmen Behrens, Luc Girard, Ignacio I Wistuba, John D Minna, David J Mangelsdorf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3001894?pdf=render |
Similar Items
-
Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
by: Jihye Kim, et al.
Published: (2015-01-01) -
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
by: Xiao Zang, et al.
Published: (2015-05-01) -
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
by: Xiao Zang, et al.
Published: (2015-01-01) -
OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer
by: Zhongyi Yan, et al.
Published: (2020-05-01) -
Artificial Intelligence in Lung Cancer Pathology Image Analysis
by: Shidan Wang, et al.
Published: (2019-10-01)